Show simple item record

dc.contributor.authorWeaver, N. A.
dc.contributor.authorZhao, L.
dc.contributor.authorBiesbroek, J. M.
dc.contributor.authorKuijf, H. J.
dc.contributor.authorAben, H. P.
dc.contributor.authorBae, H. J.
dc.contributor.authorCaballero, M. A. A.
dc.contributor.authorChappell, F. M.
dc.contributor.authorChen, Cplh
dc.contributor.authorDichgans, M.
dc.contributor.authorDuering, M.
dc.contributor.authorGeorgakis, M. K.
dc.contributor.authorvan der Giessen, R. S.
dc.contributor.authorGyanwali, B.
dc.contributor.authorHamilton, O. K. L.
dc.contributor.authorHilal, S.
dc.contributor.authorVom Hofe, E. M.
dc.contributor.authorde Kort, P. L. M.
dc.contributor.authorKoudstaal, P. J.
dc.contributor.authorLam, B. Y. K.
dc.contributor.authorLim, J. S.
dc.contributor.authorMakin, S. D. J.
dc.contributor.authorMok, V. C. T.
dc.contributor.authorShi, L.
dc.contributor.authorValdes Hernandez, M. C.
dc.contributor.authorVenketasubramanian, N.
dc.contributor.authorWardlaw, J. M.
dc.contributor.authorWollenweber, F. A.
dc.contributor.authorWong, A.
dc.contributor.authorXin, X.
dc.contributor.authorMeta, V. C. I. Map consortium
dc.contributor.authorBiessels, G. J.
dc.date.accessioned2019-09-05T09:20:07Z
dc.date.available2019-09-05T09:20:07Z
dc.date.issued2019-12
dc.identifier.citationWeaver , N A , Zhao , L , Biesbroek , J M , Kuijf , H J , Aben , H P , Bae , H J , Caballero , M A A , Chappell , F M , Chen , C , Dichgans , M , Duering , M , Georgakis , M K , van der Giessen , R S , Gyanwali , B , Hamilton , O K L , Hilal , S , Vom Hofe , E M , de Kort , P L M , Koudstaal , P J , Lam , B Y K , Lim , J S , Makin , S D J , Mok , V C T , Shi , L , Valdes Hernandez , M C , Venketasubramanian , N , Wardlaw , J M , Wollenweber , F A , Wong , A , Xin , X , Meta , V C I M C & Biessels , G J 2019 , ' The Meta VCI Map consortium for meta-analyses on strategic lesion locations for vascular cognitive impairment using lesion-symptom mapping : Design and multicenter pilot study ' , Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring , vol. 11 , pp. 310-326 . https://doi.org/10.1016/j.dadm.2019.02.007en
dc.identifier.issn2352-8729
dc.identifier.otherPURE: 147313585
dc.identifier.otherPURE UUID: c16e30ce-a475-4f7e-b18a-90da4beb6e8d
dc.identifier.otherRIS: urn:284A448D2DEA7FBCEDC25B047D71417E
dc.identifier.otherRIS: 52975
dc.identifier.otherScopus: 85064191398
dc.identifier.otherMendeley: 656786aa-a3c0-31ff-a940-977e3dd6cae2
dc.identifier.otherORCID: /0000-0001-8701-9043/work/76976263
dc.identifier.urihttp://hdl.handle.net/2164/12849
dc.descriptionAdditional grant support pilot study cohorts: The CODECS study is supported by a grant from Stichting Coolsingel, the Netherlands. Funding for the PROCRAS study was obtained through ZonMw as part of the ‘TopZorg’ project in 2015 (grant # 842003011). The CU-STRIDE study was funded by the Health and Health Services Research Fund (0708041) of the Food and Health Bureau of the Government of the Hong Kong Special Administrative Region. The CU-RISK study was funded by General Research Fund (grant number GRF CUHK 471911), the National Key Research and Development Program of China (grant number 2016YFC1300600), and the Lui Che Woo Institute of Innovative Medicine, and Therese Pei Fong Chow Research Center for Prevention of Dementia (in memory of Donald H. K. Chow). The Mild Stroke Study 2 was funded by the Wellcome Trust (WT088134/Z/09/A), the Row Fogo Charitable Trust and Chest Heart & Stroke Scotland (long-term follow-up, ref no: Res14/A157). J.M.W. is supported by the Fondation Leducq Transatlantic Network of Excellence for the Study of Perivascular Spaces in Small Vessel Disease (ref no. 16 CVD 05) and the UK Dementia Research Institute at The University of Edinburgh. O.K.L.H. is supported by the College of Medicine and Veterinary Medicine at the University of Edinburgh and the Wellcome Trust.en
dc.format.extent17
dc.language.isoeng
dc.relation.ispartofAlzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoringen
dc.rightsUnder a Creative Commons license https://creativecommons.org/licenses/by-nc-nd/4.0/en
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectCerebrovascular disease Consortium Data harmonization Lesion location Lesion-symptom mapping Small vessel disease Stroke Support vector regression Vascular cognitive impairmenten
dc.subjectLesion-symptom mappingen
dc.subjectStrokeen
dc.subjectSmall vessel diseaseen
dc.subjectLesion locationen
dc.subjectVascular cognitive impairmenten
dc.subjectConsortiumen
dc.subjectSupport vector regressionen
dc.subjectData harmonizationen
dc.subjectCerebrovascular diseaseen
dc.subjectR Medicineen
dc.subjectClinical Neurologyen
dc.subjectPsychiatry and Mental healthen
dc.subjectWellcome Trusten
dc.subject.lccRen
dc.titleThe Meta VCI Map consortium for meta-analyses on strategic lesion locations for vascular cognitive impairment using lesion-symptom mapping : Design and multicenter pilot studyen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1016/j.dadm.2019.02.007
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85064191398&partnerID=8YFLogxKen
dc.identifier.urlhttp://www.mendeley.com/research/meta-vci-map-consortium-metaanalyses-strategic-lesion-locations-vascular-cognitive-impairment-usingen
dc.identifier.urlhttps://www.ncbi.nlm.nih.gov/pubmed/31011619en


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record